324 related articles for article (PubMed ID: 20229677)
1. Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium.
Mitić G; Kovac M; Povazan L; Djordjević V; Ilić V; Salatić I; Lazić R; Antonijević N; Novakov-Mikić A
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():18-22. PubMed ID: 20229677
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
3. [Thrombophilia, preeclampsia and other pregnancy complications].
Vucić N; Frleta M; Petrović D; Ostojić V
Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
[TBL] [Abstract][Full Text] [Related]
4. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
6. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Bates SM; Greer IA; Hirsh J; Ginsberg JS
Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
[TBL] [Abstract][Full Text] [Related]
7. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
Rath W
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
[TBL] [Abstract][Full Text] [Related]
8. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
9. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Bates SM; Greer IA; Middeldorp S; Veenstra DL; Prabulos AM; Vandvik PO
Chest; 2012 Feb; 141(2 Suppl):e691S-e736S. PubMed ID: 22315276
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.
Nurmohamed MT; van Riel AM; Henkens CM; Koopman MM; Que GT; d'Azemar P; Büller HR; ten Cate JW; Hoek JA; van der Meer J; van der Heul C; Turpie AG; Haley S; Sicurella A; Gent M
Thromb Haemost; 1996 Feb; 75(2):233-8. PubMed ID: 8815566
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
Couto E; Nomura ML; Barini R; Pinto e Silva JL
Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
[TBL] [Abstract][Full Text] [Related]
14. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
Hirsh J
Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124
[TBL] [Abstract][Full Text] [Related]
16. Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.
Davis R; Faulds D
Drugs Aging; 1997 Apr; 10(4):299-322. PubMed ID: 9108990
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 12 cases with venous thromboembolism during pregnancy and puerperium].
Ma S; Bai C; Gai M
Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):649-51. PubMed ID: 11479943
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of pregnancy related venous thromboembolism].
Mitić G; Povazan L; Lucić AM
Med Pregl; 2009; 62(7-8):346-51. PubMed ID: 19902787
[TBL] [Abstract][Full Text] [Related]
19. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G
Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390
[TBL] [Abstract][Full Text] [Related]
20. Use of low molecular weight heparin in acute venous thromboembolic events in pregnancy.
Malcolm JC; Keely EJ; Karovitch AJ; Wells PS
J Obstet Gynaecol Can; 2002 Jul; 24(7):568-71. PubMed ID: 12196848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
